Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Autophagic degradation of the inhibitory p53 isoform Δ133p53α as a regulatory mechanism for p53-mediated senescence

I. Horikawa, K. Fujita, LM. Jenkins, Y. Hiyoshi, AM. Mondal, B. Vojtesek, DP. Lane, E. Appella, CC. Harris,

. 2014 ; 5 (-) : 4706. [pub] 20140821

Language English Country England, Great Britain

Document type Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't

Δ133p53α, a p53 isoform that can inhibit full-length p53, is downregulated at replicative senescence in a manner independent of mRNA regulation and proteasome-mediated degradation. Here we demonstrate that, unlike full-length p53, Δ133p53α is degraded by autophagy during replicative senescence. Pharmacological inhibition of autophagy restores Δ133p53α expression levels in replicatively senescent fibroblasts, without affecting full-length p53. The siRNA-mediated knockdown of pro-autophagic proteins (ATG5, ATG7 and Beclin-1) also restores Δ133p53α expression. The chaperone-associated E3 ubiquitin ligase STUB1, which is known to regulate autophagy, interacts with Δ133p53α and is downregulated at replicative senescence. The siRNA knockdown of STUB1 in proliferating, early-passage fibroblasts induces the autophagic degradation of Δ133p53α and thereby induces senescence. Upon replicative senescence or STUB1 knockdown, Δ133p53α is recruited to autophagosomes, consistent with its autophagic degradation. This study reveals that STUB1 is an endogenous regulator of Δ133p53α degradation and senescence, and identifies a p53 isoform-specific protein turnover mechanism that orchestrates p53-mediated senescence.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010747
003      
CZ-PrNML
005      
20160415123906.0
007      
ta
008      
160408s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/ncomms5706 $2 doi
024    7_
$a 10.1038/ncomms5706 $2 doi
035    __
$a (PubMed)25144556
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Horikawa, Izumi $u 1] Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Bethesda, Maryland 20892-4258, USA [2].
245    10
$a Autophagic degradation of the inhibitory p53 isoform Δ133p53α as a regulatory mechanism for p53-mediated senescence / $c I. Horikawa, K. Fujita, LM. Jenkins, Y. Hiyoshi, AM. Mondal, B. Vojtesek, DP. Lane, E. Appella, CC. Harris,
520    9_
$a Δ133p53α, a p53 isoform that can inhibit full-length p53, is downregulated at replicative senescence in a manner independent of mRNA regulation and proteasome-mediated degradation. Here we demonstrate that, unlike full-length p53, Δ133p53α is degraded by autophagy during replicative senescence. Pharmacological inhibition of autophagy restores Δ133p53α expression levels in replicatively senescent fibroblasts, without affecting full-length p53. The siRNA-mediated knockdown of pro-autophagic proteins (ATG5, ATG7 and Beclin-1) also restores Δ133p53α expression. The chaperone-associated E3 ubiquitin ligase STUB1, which is known to regulate autophagy, interacts with Δ133p53α and is downregulated at replicative senescence. The siRNA knockdown of STUB1 in proliferating, early-passage fibroblasts induces the autophagic degradation of Δ133p53α and thereby induces senescence. Upon replicative senescence or STUB1 knockdown, Δ133p53α is recruited to autophagosomes, consistent with its autophagic degradation. This study reveals that STUB1 is an endogenous regulator of Δ133p53α degradation and senescence, and identifies a p53 isoform-specific protein turnover mechanism that orchestrates p53-mediated senescence.
650    _2
$a adaptorové proteiny signální transdukční $x genetika $x metabolismus $7 D048868
650    _2
$a androstadieny $x farmakologie $7 D000730
650    _2
$a proteiny regulující apoptózu $x genetika $x metabolismus $7 D051017
650    _2
$a autofagie $x účinky léků $x fyziologie $7 D001343
650    _2
$a stárnutí buněk $x fyziologie $7 D016922
650    _2
$a kultivované buňky $7 D002478
650    _2
$a cykloheximid $x farmakologie $7 D003513
650    _2
$a fibroblasty $x účinky léků $x metabolismus $7 D005347
650    _2
$a genový knockdown $7 D055785
650    _2
$a lidé $7 D006801
650    _2
$a membránové proteiny $x genetika $x metabolismus $7 D008565
650    _2
$a proteiny asociované s mikrotubuly $x genetika $x metabolismus $7 D008869
650    _2
$a protein - isoformy $x metabolismus $7 D020033
650    _2
$a malá interferující RNA $7 D034741
650    _2
$a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159
650    _2
$a ubikvitinligasy $x genetika $x metabolismus $7 D044767
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Intramural $7 D052060
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Fujita, Kaori $u 1] Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Bethesda, Maryland 20892-4258, USA [2] [3].
700    1_
$a Jenkins, Lisa M Miller $u Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Bethesda, Maryland 20892-4258, USA.
700    1_
$a Hiyoshi, Yukiharu $u Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Bethesda, Maryland 20892-4258, USA.
700    1_
$a Mondal, Abdul M $u Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Bethesda, Maryland 20892-4258, USA.
700    1_
$a Vojtesek, Borivoj $u Regional Centre for Applied and Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty Kopec 7, Brno 65653, Czech Republic.
700    1_
$a Lane, David P $u Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.
700    1_
$a Appella, Ettore $u Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Bethesda, Maryland 20892-4258, USA. $7 gn_A_00007825
700    1_
$a Harris, Curtis C $u Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Bethesda, Maryland 20892-4258, USA.
773    0_
$w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 5, č. - (2014), s. 4706
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25144556 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20160415123951 $b ABA008
999    __
$a ok $b bmc $g 1114176 $s 935115
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 5 $c - $d 4706 $e 20140821 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
LZP    __
$a Pubmed-20160408

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...